Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2016 May 3;6:25478. doi: 10.1038/srep25478

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2016, Macmillan Publishers Limited

This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

PMC Copyright notice

(A) CYP2C19 LOF alleles including the genotypes *1/*2, *1/*3, *2/*2 and *2/*3. The genotype of non-carriers is CYP2C19 *1/*1. The curves represent the percentage of patients surviving at the endpoints. The numbers below the survival curves are the numbers of patients in each group who survived at the endpoints and were still at risk over the follow-up period. (B) The cumulative survival rates did not differ between the patients with the CYP2C19*2 and CYP2C19*3 alleles. These alleles are both included in the genotype *2/*3; therefore, patients with this genotype are counted twice. (C,D) The rates of recurrence of ischemic event-free survival did not differ between the two groups during the first 107 days post-CAS. After postoperative day 107, these rates were significantly different between the groups.